These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3117730)

  • 1. Immune responses in Mycoplasma pneumoniae infection of infant mouse and of man.
    Kanamori M; Katsura T; Ishiyama N; Ogata S; Kitamoto O
    Isr J Med Sci; 1987 Jun; 23(6):568-73. PubMed ID: 3117730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of colostrum in Mycoplasma pneumoniae infection induced in infant mice.
    Katsura T; Kanamori M; Kitamoto O; Ogata S
    Microbiol Immunol; 1985; 29(9):883-94. PubMed ID: 3934507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
    Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adherence protein of Mycoplasma pneumoniae as antigen for enzyme-linked immunosorbent assay (ELISA).
    Jacobs E; Buchholz A; Kleinmann B; Bredt W
    Isr J Med Sci; 1987 Jun; 23(6):709-12. PubMed ID: 3117734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection.
    Bencina D; Slavec B; Narat M
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):399-406. PubMed ID: 15708314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine.
    Zhu C; Wu Y; Chen S; Yu M; Zeng Y; You X; Xiao J; Wang S
    Can J Microbiol; 2012 May; 58(5):644-52. PubMed ID: 22540220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoblotting patterns with Mycoplasma pneumoniae of serum specimens from infected and non-infected subjects.
    Aubert G; Pozzetto B; Hafid J; Gaudin OG
    J Med Microbiol; 1992 May; 36(5):341-6. PubMed ID: 1588585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxytetracycline and erythromycin on Syrian hamsters after intratracheal infection with Mycoplasma pneumoniae.
    Ritter E; Lange A; Rockel C; Ortel J
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):83-9. PubMed ID: 3106470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.
    Hardy RD; Jafri HS; Olsen K; Wordemann M; Hatfield J; Rogers BB; Patel P; Duffy L; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2001 Jun; 69(6):3869-76. PubMed ID: 11349053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the usefulness of using western immunoblotting for testing humoral immune response to Mycoplasma pneumoniae antigens during natural infection in humans].
    Rastawicki W
    Med Dosw Mikrobiol; 1996; 48(1-2):39-48. PubMed ID: 8926766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma pneumoniae infections.
    Brunner H
    Isr J Med Sci; 1981 Jul; 17(7):516-23. PubMed ID: 6793535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of Mycoplasma pneumoniae polysaccharides.
    Brunner H
    Isr J Med Sci; 1981 Jul; 17(7):678-81. PubMed ID: 6793538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of newly established mouse strain MPS to Mycoplasma pneumoniae infection.
    Sasaki Y; Ogura A; Nakayama K; Noguchi Y; Matsuno K; Saito M
    Microbiol Immunol; 1991; 35(3):247-52. PubMed ID: 1908041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
    Ogata S; Kitamoto O
    Yale J Biol Med; 1983; 56(5-6):481-6. PubMed ID: 6433569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoblotting for determination of the antigenic specificities of antibodies to the Mycoplasmatales.
    Kenny GE; Cartwright FD
    Isr J Med Sci; 1984 Oct; 20(10):908-11. PubMed ID: 6210265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of monoclonal antibodies for the detection of Mycoplasma pneumoniae.
    Geary SJ; Ryan JA; Forsyth MH; Sasseville V
    Mol Cell Probes; 1993 Apr; 7(2):133-8. PubMed ID: 8321252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibody to Mycoplasma pneumoniae by enzyme-linked immunosorbent assay II. Serum antibody in patients with Mycoplasma pneumoniae infections.
    Miyaji T
    Sci Rep Res Inst Tohoku Univ Med; 1984 Oct; 31(1-4):13-26. PubMed ID: 6442011
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
    Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypersensitivity syndrome during Mycoplasma pneumoniae infection].
    Kosseian-Bal I; Bocquet H; Beneton N; Encaoua R; Deforges L; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1998 May; 125(5):328-30. PubMed ID: 9747281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies seroprevalence for mycoplasma pneumoniae antigens in patients with bronchial asthma].
    Friedek D; Ekiel A; Szulakowski P; Romanik M
    Wiad Lek; 2002; 55(3-4):158-63. PubMed ID: 12182000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.